{"nct_id":"NCT04895436","title":"Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2022-03-28","start_date_type":"ACTUAL","primary_completion_date":"2026-11","primary_completion_date_type":"ESTIMATED","completion_date":"2029-01","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["ABBV"]}